INDP logo

INDP
Indaptus Therapeutics Inc

15,931
Mkt Cap
$120.04M
Volume
165,726.00
52W High
$19.91
52W Low
$0.925
PE Ratio
-0.07
INDP Fundamentals
Price
$1.08
Prev Close
$1.06
Open
$1.11
50D MA
$2.12
Beta
1.24
Avg. Volume
73,553.42
EPS (Annual)
-$21.58
P/B
96.19
Rev/Employee
$0.00
$5.69
Loading...
Loading...

About

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5

Frequently Asked Questions

What is Market Cap of Indaptus Therapeutics Inc?
What is the 52-week high for Indaptus Therapeutics Inc?
What is the 52-week low for Indaptus Therapeutics Inc?
What is Indaptus Therapeutics Inc stock price today?
What was Indaptus Therapeutics Inc stock price yesterday?
What is the PE ratio of Indaptus Therapeutics Inc?
What is the Price-to-Book ratio of Indaptus Therapeutics Inc?
What is the 50-day moving average of Indaptus Therapeutics Inc?
How many employees does Indaptus Therapeutics Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available